BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14708234)

  • 21. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment for urethral recurrence after ileal neobladder reconstruction in patients with bladder cancer.
    Yoshida K; Nishiyama H; Kinoshita H; Matsuda T; Ogawa O
    BJU Int; 2006 Nov; 98(5):1008-11. PubMed ID: 17034603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy.
    Gaya JM; Matulay J; Badalato GM; Holder DD; Hruby G; McKiernan J
    Can J Urol; 2014 Apr; 21(2):7228-33. PubMed ID: 24775577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up.
    Kaouk JH; Goel RK; White MA; White WM; Autorino R; Haber GP; Campbell SC
    Urology; 2010 Oct; 76(4):857-61. PubMed ID: 20646750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment for urologic polyneoplasia].
    Leonov OV; Slonimskaia EM; Dolgikh VT
    Vopr Onkol; 2008; 54(2):220-4. PubMed ID: 18522174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early diagnostics of bladder cancer recurrence with fluorescence in situ hybridization method in the first 24 months after a transurethral resection of a bladder in old and elderly persons].
    Pushkin AS; Ryzhak GA
    Adv Gerontol; 2012; 25(4):745-8. PubMed ID: 23734524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic radical cystectomy and extracorporeal urinary diversion: a single center experience of 48 cases with three years of follow-up.
    Hemal AK; Kolla SB; Wadhwa P; Dogra PN; Gupta NP
    Urology; 2008 Jan; 71(1):41-6. PubMed ID: 18242362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient's outcome of bladder cancer managed by radical cystectomy with lymphadenectomy at a university hospital.
    Ather MH; Jamshaid A; Alam Z; Siddique KM; Sulaiman MN
    J Pak Med Assoc; 2007 Nov; 57(11):536-8. PubMed ID: 18062517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases.
    Canda AE; Atmaca AF; Altinova S; Akbulut Z; Balbay MD
    BJU Int; 2012 Aug; 110(3):434-44. PubMed ID: 22177416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP; Penson DF
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
    Hakimi AA; Ghavamian R
    Urol Clin North Am; 2011 Nov; 38(4):407-18, v. PubMed ID: 22045172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor.
    Kim W; Song C; Park S; Kim J; Park J; Kim SC; Cho YM; Hong B; Ahn H
    J Endourol; 2012 Aug; 26(8):1059-64. PubMed ID: 22390720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of urethral recurrence after radical cystectomy in the male].
    Huguet J
    Actas Urol Esp; 2012 Jan; 36(1):42-7. PubMed ID: 21821317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma.
    Ficarra V; Dalpiaz O; Alrabi N; Novara G; Galfano A; Artibani W
    BJU Int; 2005 Apr; 95(6):786-90. PubMed ID: 15794783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.